Skip to main content
. Author manuscript; available in PMC: 2012 Oct 28.
Published in final edited form as: Drug Deliv. 2011 Mar 26;18(5):377–384. doi: 10.3109/10717544.2011.567310

Figure 5.

Figure 5

In vitro cytotoxicity of a TATp-Doxil formulation towards B16-F10 and HeLa cells. The formulation was pre-treated with 0.1mg/ml trypsin for 1 hr. followed by 24 hr. incubation with cells at 370C before the viability assay. (*p≤0.05 vs. TATp-Doxil, n=5)